Advisor Group, Inc. - IMMUNE PHARMACEUTICALS INC ownership

IMMUNE PHARMACEUTICALS INC's ticker is IMNPQ and the CUSIP is 45254C200. A total of 16 filers reported holding IMMUNE PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Advisor Group, Inc. ownership history of IMMUNE PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2018$1,000
-50.0%
3,7500.0%0.00%
Q4 2017$2,000
-66.7%
3,7500.0%0.00%
Q3 2017$6,000
-50.0%
3,7500.0%0.00%
Q2 2017$12,0003,7500.00%
Other shareholders
IMMUNE PHARMACEUTICALS INC shareholders Q1 2018
NameSharesValueWeighting ↓
Virtu Financial LLC 24,681$14,0000.00%
VANGUARD GROUP INC 415,518$237,0000.00%
UBS Group AG 87,514$50,0000.00%
Advisor Group, Inc. 3,750$2,0000.00%
BANK OF AMERICA CORP /DE/ 21,594$12,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 22,355$12,0000.00%
DEUTSCHE BANK AG\ 4$00.00%
CREDIT SUISSE AG/ 23,504$14,0000.00%
MORGAN STANLEY 54$00.00%
BlackRock Inc. 568$00.00%
View complete list of IMMUNE PHARMACEUTICALS INC shareholders